In a 396-14 vote, the House of Representatives passed the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, or H.R. 6—bipartisan opioid legislation that aims to curb drug abuse.

While debates about immigration—and the controversial approach to separating families at the southwestern border of the U.S.—dominate the news, advocates warn that children may be at risk for losing healthcare coverage through Medicaid, according to a recent report from Kaiser Health News.

A congressional briefing in Washington, D.C., was held by a panel of representatives from the Medical Imaging and Technology Alliance (MITA) to discuss how medical device providers are regulated and how standards can be better aligned to ensure patient safety.

Representatives from the Medical Imaging & Technology Alliance (MITA) briefed members of Congress on June 15 about the regulation of medical device servicers and how the current structure of such regulation can result in improperly serviced equipment being used by healthcare providers.

Diabetes advocates and legislators on both sides of the aisle are calling for more transparency and government oversight in the insulin market because of skyrocketing costs.

CMS is requesting input in hopes of “reducing the regulatory burdens” of the Stark Law, which prohibits physicians from referring Medicare or Medicaid beneficiaries to entities from which the physician or an immediate family member would financially benefit.

More radiology practices reported that one of their radiologists utilized the Family and Medical Leave Act (FMLA) in 2016 than 2015, according to a new study published in the American Journal of Roentgenology. The authors noted, however, that the bump was not statistically significant.

New York and Massachusetts will sue the Trump administration following the announced expansion of association health plans, arguing the move will invite “fraud, mismanagement and deception.”